Apoptosis as a therapeutic target in acutely ischemic myocardium

Current Opinion in Cardiology

Volumn 18, Issue 5, 2003, Pages 372-377

  Garg, Shaila ^a,b   Hofstra, Leo ^c   Reutelingsperger, Chris ^c   Narula, Jagat ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HAHNEMANN UNIVERSITY HOSPITAL   (United States)

^c NONE

Author keywords

Apoptosis; Ischemia

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANNEXIN; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARIPORIDE; CARVEDILOL; CASPASE 3 INHIBITOR; CASPASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA FRAGMENT; ENIPORIDE; METOPROLOL; MINOCYCLINE; NORADRENALIN; PROTEIN BCL 2; SODIUM PROTON EXCHANGE PROTEIN; STABILIZING AGENT; TECHNETIUM 99M; TRACER;

APOPTOSIS; CELL DEATH; CLINICAL TRIAL; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; KINETICS; MITOCHONDRION; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SARCOLEMMA; SCINTIGRAPHY;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; APOPTOSIS; GENE THERAPY; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; RADIONUCLIDE IMAGING;

EID: 0141788070     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200309000-00009     Document Type: Review

References (40)

1. Dumont EA, Reutelingsperger CPM, Smits JFM, et al.: Real-time imaging of apoptotic cell-membrane changes at the single cell level in the beating murine heart. Nature Med. 2001, 12:1352-1355. This study monitored the kinetics of evolution of apoptosis in beating mouse hearts by optical imaging with the help of fluorescent Annexin-A5. The study also evaluated the effects of caspase inhibition in ischemia/reperfusion model.
2. Kajstura J, Cheng W, Reiss K, et al.: Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996, 74:86-107.
3. Dumont EA, Hofstra L, van Heerde WL, et al.: Cardiomyocyte death induced by myocardial ischemia and reperfusion- measurement with recombinant human annexin-5 in a mouse model. Circulation 2000, 102:1564-1568.
4. Veinot JP, Gattinger DA, Fliss H: Early apoptosis in human myocardial infarcts. Hum Pathol 1997, 28:485-492.
5. Saraste A, Pulkki K, Kallajoki M, et al.: Apoptosis in human acute myocardial infarction. Circulation 1997, 95:320-323.
6. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284:555-556.
7. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992, 119:493-501.
8. Blankenberg FG, Katsikis PD, Tait JF, et al.: In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 1998, 95:6349-6354.
9. Hofstra L, Liem IH, Dumont EA, et al.: Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000, 356:209-212. This study demonstrated the clinical feasibility of noninvasive detection of apoptosis in patients with acute myocardial infarction.
10. Narula J, Acio ER, Narula N, et al.: Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 2001, 7:1347-1352. This study evaluated the role of non-invasive imaging with Annexin-A5 for the detection of apoptotic process in myocardial disorders characterized by diffuse damage such as acute cardiac allograft rejection.
11. Fliss H, Gattinger D: Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996, 79:949-956.
12. Bialik S, Geenan DL, Sasson IE, et al.: Myocardial apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest 1997, 100:1363-1372.
13. Olivetti G, Quaini F, Sala R, et al.: Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in surviving portion of the heart. J Mol Cell Cardiol 1996, 28:2005-2016.
14. Thimister PWL, Hofstra L, Liem IH, et al.: In vivo detection of cell death in the area at risk in acute myocardial infarction. J Nucl Med 2003, 44:391-396. This study demonstrated evidence of apoptosis in humans undergoing acute myocardial infarction and at least partial resolution of apoptosis in the area at risk following reperfusion.
15. Narula J, Strauss HW: Implications of phosphatidyl serine reversal in acute ischemic syndromes. J Nucl Med 2003, 44:397-399. This editorial critically analyzes the value of detection of apoptosis in acute ischemia. Authors hypothesize that inhibition of apoptosis may produce wide spread protective effects.
16. Sabbah HN, Sharov VG, Goussev A, et al.: Long-term therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure [abstract]. Circulation 1998, 98:1364.
17. Feuerstein G, Yue T-L, Ma X, et al.: Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvidilol. Prog Cardiovasc Dis 1998, 41:17-24.
18. Goussev A, Sharov VG, Shimoyama H, et al.: Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure. Am J Physiol 1998, 275:H626-H631.
19. Oskarsson HJ, Coppey L, Weiss RM, et al.: Antioxidants attenuate myocyte apoptosis in the remote non-infarcted myocardium following large myocardial infarction. Cardiovasc Res 2000, 45:679-687.
20. Nicholson DW, Thornberry NA: Caspases: Killer proteases. Trends Biochem Sci 1997, 22:299-306.
21. Yaoita H, Ogawa K, Maehara K, et al.: Attenuation of Ischemia/ Reperfusion Injury in Rats by a Caspase Inhibitor. Circulation 1998, 97:276-281. This study evaluated the role of caspase inhibition in preventing apoptosis and thereby reduction of infarct size in an ischemia/reperfusion model in rabbits.
22. Communal C, Sumandea M, de Tombe P, et al.: Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U S A 2002, 99:6252-6256.
23. Holly TA, Drincic A, Byun Y, et al.: Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol 1999, 31:1709-1715.
24. Huang JQ, Radinovic S, Rezaiefar P, et al.: In vivo myocardial infarct size reduction by a caspase inhibitor administered after onset of ischemia. Eur J Pharmacol 2000, 402:139-142.
25. Okamura T, Miura T, Takamura G, et al.: Effect of caspase inhibitors on myocardial infarct size and myocyte DNA fragmentation in the ischemia-reperfused rat heart. Cardiovasc Res 2000, 45:642-650.
26. Wang TD, Chen WJ, Mau TJ, et al.: Attenuation of increased myocardial ischemia-reperfusion injury conferred by hypercholestrolemia through pharmacological inhibition of the caspase-1 cascade. Br J Pharmacol 2003, 138:291-300.
27. Humphreys RA, Haist JV, Chakrabarti S, et al.: Orally administered NHE-1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion. Am J Physiol 1999, 276:H741-H757.
28. Drexler H, Rupprecht HJ, Buerke M, et al.: a Na/K exchange inhibitor improves recovery of ventricular function in patients undergoing coronary angioplasty for acute anterior myocardial infarction [abstract]. Circulation 1998, 98:1344.
29. Nisoli E, Clementi E, Paolucci C, et al.: Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003, 299:896-899.
30. Weiland U, Haendeler J, Ihling C, et al.: Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion-induced myocardial apoptosis via a caspase-3 dependent pathway. Cradivasc Res 2000, 45:671-678.
31. Fan TM, Xu J, Pain TS, et al.: Diazoxide inhibits mitochondrial cytochrome C release in ischemic rabbit myocardium. Circulation 1999, 100:13319.
32. Scarabelli T, Stephanou A, Pasini E, et al.: Minocycline, a novel cardioprotective agent, inhibits caspase activation and reactivation by increasing the ratio of XIAP to Smac/DIABLO and reducing mitochondrial leakage of cytochrome c and Smac/DIABLO, in press.
33. Gottlieb RA, Gruol DL, Zhu JY, et al.: Preconditioning in Rabbit Cardiomyocytes Role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest 1996, 97:2391-2398.
34. Piot Ca: Martini JF, Bui SK, et al. Ischemic preconditioning attenuates ischemia/reperfusion-induced activation of caspases and subsequent cleavage of poly (ADP-ribose) polymerase in rat hearts in vivo. Cardiovasc Res 1999, 44:536-542.
35. Piot CA, Padmanaban D, Ursell PC, et al.: Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation 1997, 96:1598-1604.
36. Brochieriou V, Hagege AA, Oubenaissa A, et al.: Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med 2000, 2:326-333.
37. Maulik N, Engelman RM, Rouson JA, et al.: Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation 1999, 100:367-375.
38. Boise LH, Gonzalez-Garcia M, Postema CE, et al.: Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993, 74:597-608.
39. Adams JW, Armstrong RC, Krishenbaum LA, et al.: Bcl-2 expression inhibits GαQ induced mitochondrial C release and prevents caspase dependent cardiomyocyte apoptosis. Circulation 1999, 100:1282.
40. Jones SP, Girod WG, Stassi G, et al.: Cardiomyocyte apoptosis is attenuated following myocardial ischemia-reperfusion injury in transgenic mice overexpressing bcl-xl in the heart. Circulation 1998, 98:115.